Systematic review and meta-analysis concerning the efficacy and effectiveness of seasonal influenza vaccines – (part 2)Archived
Systematic review and meta-analysis concerning the efficacy and effectiveness of seasonal influenza vaccines
Osterholm MT, Kelley NS, Sommer A, et al. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis The Lancet Infectious Diseases, Early Online Publication, 26 October 2011
There are several factors that can influence vaccine efficacy and effectiveness estimation. To try to avoid them, the authors have used particularly restrictive study inclusion criteria to minimise bias and confounding, and excluded randomised controlled trials in which the comparison group did not receive either placebo or a vaccine other than influenza. The results show that evidence for consistent high-level protection is elusive and there are still important knowledge gaps that should be filled in to better inform vaccination policies. In particular vaccine effectiveness studies should be systematically implemented in order to assess the real impact of vaccination programmes in relation to the different match between vaccine antigens and circulating strains during different seasons. Having said all that, and noting that it is important not to overstate the effectiveness of influenza, ECDC points out that the regular seasonal influenza vaccine remains the singly most effective way of protecting individuals against actual influenza.
World Health Organization recommendations for the influenza virus vaccine composition for the 2020 southern hemisphere season
11 Oct 2019 - On September 2019, WHO has agreed on the recommended composition of the quadrivalent and trivalent influenza vaccines for the southern hemisphere 2020 influenza season.
WHO recommendations for influenza virus vaccine composition for the 2019–2020 northern hemisphere season
1 Mar 2019 - On 18–20 February 2019, the World Health Organization (WHO) agreed on the recommended composition of the quadrivalent influenza vaccine for the northern hemisphere 2019–2020 influenza season: an A/Brisbane/02/2018 (H1N1)pdm09-like virus, an A(H3N2) virus component to be announced on 21 March 2019, a B/Colorado/06/2017-like virus (B/Victoria/2/87 lineage) and a B/Phuket/3073/2013-like virus (B/Yamagata/16/88 lineage).
WHO recommendations for influenza virus vaccine composition for the 2018-2019 Northern hemisphere season
26 Feb 2018 - On 19-21 February 2018 the World Health Organization (WHO) agreed on the recommended composition of the trivalent influenza vaccine for the northern hemisphere 2018-2019 influenza season.